Dr. Aggarwal on Triplet Therapy in EGFR-Mutant Lung Cancer

Targeted treatment with EGFR TKIs: Front line optionsПодробнее

Part 6 - Optimal Management of EGFR Mutation Positive Advanced Lung Cancer - Dr Shyam AggarwalПодробнее

Part 6 - Optimal Management of EGFR Mutation Positive Advanced Lung Cancer - Dr Shyam AggarwalПодробнее

Repeat biopsy in lung cancer patients with EGFR mutationПодробнее

Current treatment recommendations and future directions for EGFR-mutant NSCLCПодробнее

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

How do doctors treat lung cancer with EGFR mutations?Подробнее

EGFR-Mutant Lung Cancer: Initial ApproachПодробнее

Dr. Yu on Treatments for EGFR-Mutant Lung CancerПодробнее

Dr. Piotrowska on Treatment for EGFR-Mutant NSCLCПодробнее

Charu Aggarwal, MD, MPH, on how the findings from the FLAURA and ADURA impact EGFR NSCLC managementПодробнее

Osimertinib for EGFR-mutant lung cancerПодробнее

Future Research and Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Dr. Wakelee on First-Line Therapy for EGFR-Mutant Lung CancerПодробнее

Current Role of Immunotherapy in EGFR-Mutant Lung CancerПодробнее

EGFR Mutations in Advanced NSCLC - Targeted Therapies in Lung Cancer 2023Подробнее

Response to systemic anti-cancer therapy in uncommon EGFR mutationsПодробнее

EGFR-Mutant Lung Cancer: A Patient's JourneyПодробнее

Brain Metastases in EGFR-Mutant Lung Cancer | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Management of EGFR-Mutant Lung Cancer With Central Nervous System MetastasesПодробнее